Haptogen Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 20
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Haptogen General Information

Description

Provider of drug development services intended for discovery and optimization of protein therapeutics. The company's drug development services involves engineering antibodies to develop more tailored and less toxic treatment for key diseases such as cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Primary Office
  • Polwarth Building
  • Foresterhill
  • Aberdeen AB25 2ZD
  • Scotland, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Haptogen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Haptogen‘s full profile, request access.

Request a free trial

Haptogen Patents

Haptogen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0614568-D0 Anti-testosterone antibodies Ceased 21-Jul-2006 000000000
AU-2005243459-A1 Methods for reducing biofilm formation in infectious bacteria Granted 15-May-2004 000000000
US-20090117109-A1 Methods for reducing biofilm formation in infectious bacteria Abandoned 15-May-2004 000000000 00
JP-2008502710-A Method for reducing biofilm formation in infectious bacteria Pending 15-May-2004 000000000 0
JP-2011042651-A Method for reducing biofilm formation in infectious bacteria Ceased 15-May-2004 C07K16/44 0

Haptogen Executive Team (2)

Name Title Board Seat Contact Info
Jim Reid Co-Founder & Chief Executive Officer
Andrew Porter Ph.D Co-Founder & Chief Scientific Officer
To view Haptogen’s complete executive team members history, request access »

Haptogen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial